Back
Structure Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9
GPCR
Structure Therapeutics
Last Price:
$19.55
Seasonality Move:
32.88%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.11 | Buy |
| 20-day SMA: | 20.38 | Sell |
| 50-day SMA: | 22.25 | Sell |
| 200-day SMA: | 27.23 | Sell |
| 8-day EMA: | 15.96 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.69 | Buy |
| 200-day EMA: | 1.3 | Buy |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.27 | Buy |
| Relative Strength Index (14 RSI): | 41.51 | Sell |
| Chaikin Money Flow: | 354189 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.44 - 21.9) | Sell |
| Bollinger Bands (100): | (18.66 - 24.42) | Sell |
Structure Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 19.60 while GPCR 8-day simple moving average is 19.11, which is a Buy signal.
-
The stock price of GPCR is 19.60 while Structure Therapeutics 20-day SMA is 20.38, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 22.25 while GPCR share price is 19.60, making it a Sell technically.
-
GPCR stock price is 19.60 and Structure Therapeutics 200-day simple moving average is 27.23, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
9
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $19.60. The Score for GPCR is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.1B
Price in USD:
19.60
Share Volume:
544.9K
Structure Therapeutics 52-Week Range
52-Week High:
45.37
52-Week Low:
13.22
Sell
9
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 19.60 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 19.60 while GPCR 8-day exponential moving average is 15.96, which is a Buy signal.
-
The stock price of GPCR is 19.60 while Structure Therapeutics 20-day EMA is 9.68, which makes it a Buy.
-
Structure Therapeutics 50-day exponential moving average is 4.69 while GPCR share price is 19.60, making it a Buy technically.
-
GPCR stock price is 19.60 and Structure Therapeutics 200-day simple moving average is 1.30, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.77 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is 5.27, suggesting Structure Therapeutics is a Buy
-
Structure Therapeutics Relative Strength Index (RSI) is 41.51, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (19.44 - 21.9), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (18.66 - 24.42), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.